ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 364830 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 364830; 2) Community: the network communities that were significantly associated with the response to NSC 364830; 3) Molecule: the relationships between components within communities and NSC 364830; 4) MDR: the compounds that were significantly associated with the NSC 364830.

NSC Compound Enrichment Correlation
NSC 627991 Benzo[g]pteridine-2,4-dione, 8-chloro-10-(4-chlorophenyl)- 3-methyl- 0.0480633950058473 -0.16900672
NSC 672120 Oxireno[9,10]cyclodeca[1,2-b]furan-6,9(7H,10aH)-dione, 1a,2,3,7a,8,10b-hexahydro-1a,5-dimethyl-8-methylene-, stereoisomer 0.0480633950058473 -0.087360273
NSC 613012 BENGAMIDE A 0.0480633950058475 0.21419453
NSC 679516 Null 0.0480633950058475 -0.032394663
NSC 693322 Hydrazinecarbothioamide, 2,2'-(1,2-ethanediylidene)bis[N,N-dimethyl- 0.0480633950058475 0.38571807
NSC 710326 Null 0.0480633950058475 0.17170392
NSC 718781 Erlotinib hydrochloride 0.0480633950058475 -0.097748333
NSC 726217 Combretastatin A4-analogue 0.0480633950058475 0.081268928
NSC 762346 Null 0.0480633950058475 0.21711093
NSC 606497 Camptothecin Derivative 2.35849867074422e-006 0.93058608
Total:53  Current:52    [First] [Prev] [Next] [Last]